---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-105591"
form_type: "8-K"
ticker: "ELV"
cik: "0001156039"
company_name: "Elevance Health, Inc."
filed_at: "2023-04-19T23:59:59+00:00"
generated_at: "2026-06-16T23:22:01.807139+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Elevance Health Q1 EPS $8.30 GAAP, $9.46 adjusted; raises full-year guidance

## Summary
- GAAP net income $8.30/share; adjusted net income $9.46/share, beating expectations.
- Operating revenue $41.9B, up 10.6% YoY; operating gain $2.8B, up 16.6% YoY.
- Medical enrollment 48.1M, up 1.3M YoY driven by Medicaid, Medicare Advantage, ACA.
- Raised 2023 outlook: GAAP EPS >$29.50, adjusted EPS >$32.70.
- Q2 dividend $1.48/share declared; payable June 23 to holders of record June 9.

## SEC filing metadata
- accession: 0001193125-23-105591
- form_type: 8-K
- ticker: ELV
- cik: 0001156039
- company_name: Elevance Health, Inc.
- filed_at: 2023-04-19T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1156039/000119312523105591/0001193125-23-105591-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1156039/000119312523105591/d490195d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-105591
- JSON: https://secwatch.observer/filing/0001193125-23-105591.json
- Plain text: https://secwatch.observer/filing/0001193125-23-105591.txt

## Key facts
- Earnings Releases
  Elevance Health, Inc. reported the quarter ended March 31, 2023 results: revenue $41.9 billion, net income $8.30 per share, EPS $8.30 per share. Guidance raised.
  - Period: the quarter ended March 31, 2023
  - Revenue: $41.9 billion
  - Net income: $8.30 per share
  - EPS: $8.30 per share
  - Guidance: raised
  - Result: reported results
  source text: was $8.30 per share, including net negative adjustment items of $1.16 per share. Adjusted net income was $9.46* per share. • Operating revenue grew 10.6% year-over-year to $41.9 billion • Operating gain grew 16.6% year-over-year to $2.8 billion • Medical enrollment increased 1.3 million members year-over-year to 48.1 million members • Second quarter 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/1156039/000119312523105591/0001193125-23-105591-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.